- Home
- HP vs RDY Comparison
HP vs RDY Comparison
Compare HP & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HP
- RDY
- Stock Information
- Founded
- HP 1920
- RDY 1984
- Country
- HP United States
- RDY India
- Employees
- HP N/A
- RDY N/A
- Industry
- HP Oil & Gas Production
- RDY Biotechnology: Pharmaceutical Preparations
- Sector
- HP Energy
- RDY Health Care
- Exchange
- HP Nasdaq
- RDY Nasdaq
- Market Cap
- HP 1.9B
- RDY 2.1B
- IPO Year
- HP N/A
- RDY N/A
- Fundamental
- Price
- HP $15.25
- RDY $14.71
- Analyst Decision
- HP Hold
- RDY Buy
- Analyst Count
- HP 11
- RDY 1
- Target Price
- HP $27.90
- RDY $17.00
- AVG Volume (30 Days)
- HP 2.2M
- RDY 1.6M
- Earning Date
- HP 05-07-2025
- RDY 05-09-2025
- Dividend Yield
- HP 6.56%
- RDY 0.65%
- EPS Growth
- HP N/A
- RDY 1.46
- EPS
- HP 2.20
- RDY 0.79
- Revenue
- HP $3,084,858,000.00
- RDY $3,809,801,863.00
- Revenue This Year
- HP $37.71
- RDY $10.24
- Revenue Next Year
- HP $4.61
- RDY N/A
- P/E Ratio
- HP $6.94
- RDY $18.43
- Revenue Growth
- HP 12.23
- RDY 16.61
- 52 Week Low
- HP $14.65
- RDY $12.26
- 52 Week High
- HP $42.60
- RDY $16.89
- Technical
- Relative Strength Index (RSI)
- HP 28.54
- RDY 63.81
- Support Level
- HP $15.03
- RDY $14.24
- Resistance Level
- HP $15.71
- RDY $14.77
- Average True Range (ATR)
- HP 0.66
- RDY 0.20
- MACD
- HP -0.09
- RDY 0.04
- Stochastic Oscillator
- HP 10.91
- RDY 95.59
About HP Helmerich & Payne Inc.
Helmerich & Payne Inc provides performance-driven drilling solutions and technologies that are intended to make hydrocarbon recovery safer and more economical for oil and gas exploration and production companies. The Company focus on the drilling segment of the oil and gas production value chain. Company operates in North America, Gulf of Mexico, and other international places such as Argentina, Australia, Bahrain, Colombia and the United Arab Emirates (UAE). Also own and operates a limited number of commercial real estate properties located in Tulsa, Oklahoma. It's real estate investments include a shopping center and of undeveloped real estate projects.
About RDY Dr. Reddy's Laboratories Ltd
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.